Lv642
2780 积分 2023-09-02 加入
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
2天前
已完结
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications
2天前
已完结
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
2天前
已完结
Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc
5天前
已完结
c-Myc-Targeting PROTAC Based on a TNA-DNA Bivalent Binder for Combination Therapy of Triple-Negative Breast Cancer
5天前
已完结
Perturbation of the c-Myc–Max Protein–Protein Interaction via Synthetic α-Helix Mimetics
5天前
已完结
Directly Suppressing MYC Function with Novel Alkynyl-Substituted Phenylpyrazole Derivatives that Induce Protein Degradation and Perturb MYC/MAX Interaction
5天前
已完结
Discovery of a Pyrazolopyridinone-Based MYC Inhibitor That Selectively Engages Intracellular c-MYC and Disrupts MYC–MAX Heterodimerization
5天前
已完结
The effects of MYC on tumor immunity and immunotherapy
6天前
已完结
Transcriptional regulation by MYC: an emerging new model
6天前
已完结
皖公网安备34019202002308
